Sign in

You're signed outSign in or to get full access.

Joseph Chee

Executive Chairman at Solana
Executive
Board

About Joseph Chee

Joseph Chee is Executive Chairman of the Board at Solana Company (f/k/a Helius Medical Technologies, Inc.) since September 18, 2025; the Board has determined he is not independent under Nasdaq rules and he serves as non‑independent Chair separate from the CEO role . On October 30, 2025, a subsidiary (Solana Company HK) entered into an Employment Agreement with Chee that provides executive compensation (base salary, bonus) in addition to his Executive Chairman Agreement . He holds advanced degrees including a Doctorate in applied finance (University of Geneva), an EMBA (Tsinghua), an MBA (NYU), and a BS in mechanical engineering (Stevens Institute of Technology) . As of October 1, 2025, he beneficially owned 6,830,401 shares (16.95% of shares outstanding), indicating significant alignment with stockholders .

Board service history and governance implications:

  • Board service: Executive Chairman since Sep 2025; term to the 2026 annual meeting; not independent .
  • Committee roles: The three standing committees (Audit, Compensation, Nominating & Corporate Governance) are chaired by independent directors; Chee is not listed as a committee member .
  • Dual-role implications: Non‑independent Chair with separate CEO structure; Board cites this separation as enhancing oversight; however, Chair non‑independence elevates governance risk and necessitates robust independent committees and oversight .

Past Roles

OrganizationRoleYearsStrategic Impact
UBS AGHead of Investment Banking and Head of Global Capital Markets, Asia2000–2017Led capital markets and IB across Asia; deep capital formation expertise relevant to financing strategy
Summer Capital LimitedFounder & ChairmanAug 2017–presentEarly-growth investor in fintech, blockchain, consumer tech, healthcare; informs digital asset strategy and capital allocation

External Roles

OrganizationRoleYearsStrategic Impact
AMINA Bank AG (FINMA-regulated crypto bank)Vice ChairmanApr 2020–presentBridges TradFi and digital assets; domain expertise for company’s digital asset treasury initiative
Summer Healthcare Fund, L.P.FounderFeb 2021–presentHealthcare/biotech investing; network for partnerships/pipeline
Summer Everest Ecosystem Fund, L.P.FounderSep 2023–presentBlockchain ecosystem and fintech focus; potential strategic synergies

Fixed Compensation

ComponentAmount/TermsEffective Date(s)Notes
Base Salary$525,000 per year Oct 30, 2025Employment Agreement with Solana Company (Hong Kong) Limited; annually reviewed
Sign-on Cash Bonus$61,250 Oct 30, 2025In consideration of work from Sep 18, 2025 to Oct 30, 2025

Non‑employee director compensation policy (cash retainers, committee fees, equity retainer) applies to non‑employee directors; as Executive Chairman and executive, Chee’s compensation is governed by his agreements rather than the standard non‑employee director schedule .

Performance Compensation

Incentive TypeTarget/GrantMetric(s)Actual/PayoutVesting/Conditions
Annual Cash BonusTarget of 100% of base salary Discretionary (no specific metrics disclosed) Not disclosedDetermined annually; Employment Agreement
RSU Equity Award (Executive Chairman Agreement)RSUs equal to 1% of Cash Shares + Pre‑Funded Warrant Shares issued in the Offerings, plus 0.5% of the shares underlying Stapled Warrants; calculated at 1,109,118 RSUs Service related to implementing digital asset treasury Not disclosedSubject to stockholder approval of increase in 2022 EIP shares; RSUs subject only to the same restrictions as pre‑funded/stapled warrants, if applicable
Additional RSU Award (post‑exercise)Additional RSUs equal to 0.5% of Cash Stapled Warrants exercised (within 10 business days of exercise) Triggered by investor cash exercises of Stapled WarrantsNot disclosedSame plan approval condition; restrictions mirror underlying instruments where applicable

The Compensation Committee administers the company’s clawback policy (Policy for the Recovery of Erroneously Awarded Compensation) and oversees compensation risk; no specific Chee KPI weightings were disclosed .

Equity Ownership & Alignment

MeasureDetail
Beneficial Ownership6,830,401 shares; 16.95% of class as of Oct 1, 2025
Shares Outstanding (reference)40,299,220 as of Oct 1, 2025
Ownership BreakdownTable methodology attributes beneficial ownership to shares and derivatives exercisable/vestable within 60 days; specific Chee footnote breakdown not provided in excerpts
Hedging/PledgingInsider Trading Policy prohibits hedging/monetization transactions; excerpts reviewed do not explicitly state pledging prohibitions
Stock Ownership GuidelinesNot disclosed in excerpts for executives/directors (no specific multiples or compliance status found)
Potential Dilution/Related PartySummer Wisdom Holdings Limited (“Summer”), controlled by Chee, received Strategic Advisor Warrants: Base 2,218,236 warrants (3% of Cash+Pre‑Funded Warrant Shares) and eligible for additional Performance Warrants tied to Stapled Warrant exercises, with exercise price $0.001, term 5 years, cashless exercise, share‑settled; exercisable only upon stockholder approval; unvested terminate at expiry

Employment Terms

AgreementTerm/ScopeEconomicsTermination/COCOther Terms
Executive Chairman Agreement (Sep 18, 2025)One‑year term from Effective Date; Board member until next annual meeting; duties include implementing digital asset treasury Equity RSUs as specified above; expense reimbursement; D&O indemnification Upon termination, compensation/expenses through termination; no severance specified in excerpt May engage in other activities if no conflict; non‑competition with Company without approval; access to books/records
Employment Agreement (Oct 30, 2025) with Solana Company HKExecutive employment $525,000 base; $61,250 sign‑on; target annual bonus 100% of base; additional incentives per separate grant letter Severance/COC terms not disclosed in the 8‑K summary excerpt Standard indemnification agreement also referenced at director appointment; amended and restated indemnification agreements in Sep 2025 for directors and officers

Board Governance Summary

  • Structure and Independence: Chee serves as non‑independent Chair; board cites separation of Chair and CEO as current leadership structure .
  • Committees (2024–2025): Audit (Chair: Paul Buckman; all members independent; 5 meetings in 2024), Compensation (Chair: Edward M. Straw; all independent; 1 meeting in 2024), Nominating & Corporate Governance (Chair: Sherrie Perkins) .
  • Attendance: The board met four times in 2024; each then‑serving director attended ≥75% of meetings (Chee was not yet a director in 2024) .

Related Party Transactions (Key)

  • Strategic Advisor Agreement (Sep 15, 2025): Company engaged Pantera and Summer (controlled by Chee) as strategic advisors on crypto technology; Summer received Strategic Advisor Warrants (Base and Performance) at $0.001 strike, five‑year term, cashless, share‑settled, exercisable only upon stockholder approval under Nasdaq Rule 5635(a). Failure to obtain approval renders these warrants non‑exercisable .
  • Executive Chairman Agreement (Sep 18, 2025): RSU awards to Chee sized as a percentage of securities issued in Offerings and future Cash Stapled Warrant exercises; subject to stockholder approval of share increase under the 2022 EIP .

Risk Indicators & Red Flags

  • Non‑independent Chair: Concentration of influence at board level; mitigated by independent committee leadership .
  • Related Party Equity Economics: Summer (controlled by Chee) granted deeply in‑the‑money ($0.001) warrants contingent on stockholder approval; structure could create perceived conflicts and dilution risk if approved .
  • Compensation Metric Opacity: Employment Agreement provides a 100% target bonus but does not disclose specific performance metrics, reducing pay‑for‑performance transparency .
  • Governance Controls: Company maintains an insider trading policy with hedging prohibitions and pre‑clearance/blackouts, and a clawback policy administered by the Compensation Committee .

Investment Implications

  • Alignment and Control: Chee’s 16.95% beneficial stake signals strong alignment and potential influence over strategic direction and capital allocation .
  • Dilution/Approval Watch: Shareholder votes on (i) plan share increases enabling Chee’s RSU grants and (ii) exercisability of Strategic Advisor Warrants are key catalysts; approval would unlock meaningful incremental equity to Chee/Summer, potentially impacting float and future selling pressure dynamics .
  • Execution Focus: His mandate explicitly includes implementing a digital asset treasury; his AMINA/Summer background suggests capability, but execution entails regulatory/market risks; compensation tied to Offerings‑based instruments and Stapled Warrant activity partly shifts incentives toward financing outcomes over operating KPIs unless further metrics are adopted .
  • Governance Monitoring: Non‑independent Chair structure elevates the importance of robust independent committees; investors should monitor committee oversight, related‑party transaction approvals, and any future changes to Chee’s employment or equity terms .

Note: Information reflects disclosures in the company’s 8‑Ks (Sep 18, 2025; Nov 5, 2025), PRE 14A (Oct 2, 2025), and DEF 14A (Oct 14, 2025). Specific severance/COC economics, pledging policy, and detailed KPI weightings were not disclosed in the excerpts reviewed.